Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Find the latest information on COVID-19, monkeypox, and the flu vaccine

Verapamil for severe hyperkinetic movement disorders MOVEMENT DISORDERS Ovsiew, F., Meador, K. J., Sethi, K. 1998; 13 (2): 341-344

Abstract

The use of verapamil in three cases of severe hyperkinetic movement disorders resulted in dramatic improvement in patients who had been refractory to many other treatments over a prolonged period. A videotape illustration of one of the patients is provided. The mechanism of action and evidence of efficacy of calcium-channel blockers for abnormal movements are discussed.

View details for Web of Science ID 000072468100023

View details for PubMedID 9539352